120 related articles for article (PubMed ID: 8327653)
1. Neurological Wilson's disease.
McIntyre N
Q J Med; 1993 May; 86(5):349-50. PubMed ID: 8327653
[No Abstract] [Full Text] [Related]
2. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
Yarze JC
Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
[No Abstract] [Full Text] [Related]
3. Trientine for Wilson's disease.
Med Lett Drugs Ther; 1986 Jul; 28(717):67. PubMed ID: 3724656
[No Abstract] [Full Text] [Related]
4. Wilson's disease and pregnancy.
Sternlieb I
Hepatology; 2000 Feb; 31(2):531-2. PubMed ID: 10655282
[No Abstract] [Full Text] [Related]
5. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
[TBL] [Abstract][Full Text] [Related]
6. [Triethylene tetramine in Wilson's disease].
Rave D; Vengrover D; Kleinman J; Leitersdorf E
Harefuah; 1986 Feb; 110(4):178-9. PubMed ID: 3721331
[No Abstract] [Full Text] [Related]
7. Treatment of Wilson's disease.
Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
[No Abstract] [Full Text] [Related]
8. Neurological abnormalities in Wilson's disease are reversible.
Lingam S; Wilson J; Nazer H; Mowat AP
Neuropediatrics; 1987 Feb; 18(1):11-2. PubMed ID: 3561699
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Haslam RH; Sass-Kortsak A; Stout W; Berg M
Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
[TBL] [Abstract][Full Text] [Related]
10. The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).
Walshe JM
Prog Clin Biol Res; 1979; 34():271-80. PubMed ID: 531055
[No Abstract] [Full Text] [Related]
11. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
12. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
Günther K; Siegemund R; Lössner J; Kühn HJ
Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
[No Abstract] [Full Text] [Related]
13. Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.
Harders H; Cohnen E
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):10-2. PubMed ID: 122652
[No Abstract] [Full Text] [Related]
14. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
Ritland S
Tidsskr Nor Laegeforen; 1987 Aug; 107(22):1770-1. PubMed ID: 3660361
[No Abstract] [Full Text] [Related]
15. Wilson's disease: a 1984 perspective.
Ede RJ; Mowat AP
Compr Ther; 1984 Dec; 10(12):40-7. PubMed ID: 6518737
[No Abstract] [Full Text] [Related]
16. [Wilson's disease (hepatolenticular degeneration)].
Dalmau Obrador J; Martí-Vilalta JL; Aguilar Barberá M
Med Clin (Barc); 1984 Jun; 83(2):78-85. PubMed ID: 6381924
[No Abstract] [Full Text] [Related]
17. [Treatment of Wilson's disease using triethylenetetramine dihydrochloride (TETA)].
Hauftová D; Körbel J; Jancík F; Kuhr I; Ferenc M
Cesk Gastroenterol Vyz; 1978 Dec; 32(8):538-9. PubMed ID: 737791
[No Abstract] [Full Text] [Related]
18. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
19. Drug therapy in Wilson's disease.
Reed K
J Am Optom Assoc; 1988 Jun; 59(6):438. PubMed ID: 3403885
[No Abstract] [Full Text] [Related]
20. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
Leinweber B; Möller JC; Scherag A; Reuner U; Günther P; Lang CJ; Schmidt HH; Schrader C; Bandmann O; Czlonkowska A; Oertel WH; Hefter H
Mov Disord; 2008 Jan; 23(1):54-62. PubMed ID: 17960799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
